← brief for 2026-08-15 · Slowing decline

Exploring the Clinical Pharmacokinetics of Sitagliptin in Healthy and Diseased Populations: A Systematic Critical Review

Paper B Peer reviewed Small trial

Key takeaways

A review of how sitagliptin affects drug levels in people with kidney disease. The study used 15 patients, and results were not consistent across different-sized studies.

Who did this work

Tahir Saleem (Bahauddin Zakariya University) · Muhammad Fawad Rasool (Bahauddin Zakariya University) · Hamid Saeed (University of the Punjab) · Faleh Alqahtani (King Saud University)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-14
https://doi.org/10.1097/ftd.0000000000001506